IPO Premiums
IPO calendar
CBListed

Concord Biotech Limited

Book Built Issue IPO · NSE, BSE

Price band
₹705 - ₹741
Lot size
20 shares
Issue amount
₹1,551 cr
Total subscription
26.13×
Current price₹1,285.8
Listing price ₹900.05
Watch live price ↗
Opens
4 Aug 2023
Closes
8 Aug 2023
Allotment
14 Aug 2023
Listing
18 Aug 2023

Offer at a glance

Issue overview

Issue size
2,09,25,652 shares
Face value
₹1 Per Share
Minimum investment
₹14,100
Fresh issue
₹0 cr
Offer for sale
₹1,551 cr
Registrar
Link Intime India Private Limited
Listing exchange
NSE, BSE
Maximum investment
₹14,820
Issue type
Book Built Issue IPO
Shares before issue
0
Shares after issue
10,46,16,204

Lot sizes

CategoryLotsSharesAmount
RETAIL120₹14,820
sHNI14280₹2,07,480
bHNI681,360₹10,07,760

Share reservation

QIB49.98%
NII (HNI)14.99%
RETAIL34.98%
Employee0.05%

Subscription & GMP

Subscription by category

Total subscribed26.13×

Missing multiples are calculated from bids and offered shares when available.

QIB71.12×
NIB17.86×
HNIs(10L +)20.29×
HNIs (2-10L)13×
RETAIL3.97×
EMPLOYEES25.72×

GMP history

062.512519 Mar: ₹1257 Nov: ₹125
19 Mar₹1257 Nov

Subscription demand

Amounts in ₹ crore. HNI subcategories are included in the NII total.

CategoryOfferedDemand
QIBs294.9120,975.08
RETAIL516.092,050.34
NIB221.183,949.83
HNIs 2+73.73958.56
HNIs 10+147.462,991.27
EMPLOYEES0.718.13

Financial performance

Company financials

In Crores · Reported periods may include interim results.

Revenue & profit In Crores
05001,00031 Mar 2023 · Revenue: 888.4831 Mar 2023 · Profit after tax: 240.0831 Mar 202331 Mar 2022 · Revenue: 736.3531 Mar 2022 · Profit after tax: 174.9331 Mar 202231 Mar 2021 · Revenue: 630.7531 Mar 2021 · Profit after tax: 234.8931 Mar 2021
RevenueProfit after tax

Key performance indicators

MetricValues
EPS20.79
ROE20.06
ROCE24.27
RONW20
PRE IPO(PE)32.29
POST IPO(PE)0

Values and labels as reported in the issue data.

Company information

Company profile

Incorporated in 1984, Concord Biotech Limited is an India-based biopharmaceutical company and a leading global developer and manufacturer of fermentation-based APIs, specializing in immunosuppressants and oncology. The company has a strong global presence, supplying products to over 70 countries including the USA, India, Europe, and Japan. Concord Biotech manufactures Active Pharmaceutical Ingredients (APIs) through fermentation and semi-synthetic processes, along with finished formulations. Starting with a single product, the company has expanded to offer a broad spectrum of biopharma solutions, establishing itself as a key player in the global API market.

Promoters

Mr. Sudhir Vaid

Mr. Ankur Vaid

Registrar & documents

Lead manager

Kotak Mahindra Capital Company Limited, Citigroup Global Markets India Private Limited, Jefferies India Private Limited

Registered office

1482-86, Trasad Road Dholka, Ahmedabad – 382225

079-6813 8700

[email protected]Company website ↗

Frequently Asked Questions

What is Concord Biotech IPO GMP today?

As of today, Concord Biotech IPO Grey Market Premium (GMP) is reported at +₹125 per share. Based on the upper price band of ₹741, the estimated listing price is ₹866 (+16.9% expected listing gain). Please note that GMP is an unofficial market estimate for sentiment tracking and does not guarantee the actual listing price.

What is the lot size and minimum investment for Concord Biotech IPO?

The minimum bid lot size for Concord Biotech IPO is 20 shares. At the cut-off price of ₹741 per share, retail investors need a minimum application amount of ₹14,820 per lot. Retail applicants can apply for a maximum of 13 lots (up to ₹2,00,000).

When will Concord Biotech IPO allotment status be announced?

The allotment status for Concord Biotech IPO is scheduled to be finalized on 14 Aug 2023. If you applied for the IPO, you can verify whether shares have been allocated to your Demat account through Link Intime India Private Limited's official portal or via BSE/NSE allotment portals.

How can I check Concord Biotech IPO allotment status online by PAN?

To check Concord Biotech IPO allotment status: 1) Visit the registrar portal (Link Intime India Private Limited) or the BSE IPO allotment page. 2) Select 'Concord Biotech Limited' from the company dropdown. 3) Choose 'PAN' as your identification mode and enter your 10-digit Permanent Account Number. 4) Click 'Search' to view your allotted share quantity and application status.

Explore More IPO Analysis & Live Tools

Compare the price band and required investment with company financials and official offer documents. Grey market premium (GMP) figures are indicative market estimates collected from primary market brokers and do not establish the official listing price.

Regulatory Disclaimer: Grey Market Premium (GMP) is an unofficial, unregulated indicator of market sentiment and does not represent a stock exchange transaction, guarantee, or investment advice. IPO Premiums is an informational and research portal and is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before applying for any IPO.
Concord Biotech IPO GMP Today, Subscription Status & Allotment Date | IPO Premiums